Stay updated on Volitinib for Primary CNS Tumors Clinical Trial
Sign up to get notified when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.

Latest updates to the Volitinib for Primary CNS Tumors Clinical Trial page
- Check6 days agoChange DetectedThe page revision indicator was updated from v3.6.2 to v3.6.3, signaling an update to the page template or platform components.SummaryDifference0.0%

- Check13 days agoChange DetectedSavolitinib study results have been posted and the study details have been updated. The Volitinib entry was removed, refocusing the page on the Savolitinib trial.SummaryDifference4%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page now indicates the study is no longer recruiting participants. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was standardized with a revision note (v3.6.0).SummaryDifference0.4%

- Check34 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new revision of the page/template.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page’s footer “Revision” was updated from **v3.5.0** to **v3.5.3**, indicating a ClinicalTrials.gov software/version release rather than any change to the study details.SummaryDifference0.0%

Stay in the know with updates to Volitinib for Primary CNS Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Volitinib for Primary CNS Tumors Clinical Trial page.